Lantheus Holdings Inc. (NASDAQ:LNTH) shares saw an uptick in trading volume on Monday . 380,521 shares were traded during mid-day trading, an increase of 24% from the previous session’s volume of 306,525 shares.The stock last traded at $5.00 and had previously closed at $4.65.

A number of research firms recently commented on LNTH. Zacks Investment Research lowered shares of Lantheus Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, July 6th. Jefferies Group reaffirmed a “buy” rating on shares of Lantheus Holdings in a research note on Wednesday, May 4th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of Lantheus Holdings in a research note on Monday, April 11th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Lantheus Holdings currently has an average rating of “Hold” and an average price target of $5.55.

The stock has a 50 day moving average price of $2.99 and a 200-day moving average price of $2.39. The company’s market capitalization is $158.38 million.

Lantheus Holdings (NASDAQ:LNTH) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $0.34 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.28. The business had revenue of $76.50 million for the quarter, compared to the consensus estimate of $72.43 million. Analysts expect that Lantheus Holdings Inc. will post $0.35 earnings per share for the current year.

A hedge fund recently raised its stake in Lantheus Holdings stock. Numeric Investors LLC raised its position in Lantheus Holdings Inc. (NASDAQ:LNTH) by 42.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 525,258 shares of the company’s stock after buying an additional 156,084 shares during the period. Numeric Investors LLC owned about 1.67% of Lantheus Holdings worth $1,775,000 at the end of the most recent reporting period.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.